| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.006 |
| mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.007 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.15 | 0.008 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.13 | 0.009 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.12 | 0.01 |
| mRNA | NSC-207895 | GDSC1000 | pan-cancer | AAC | 0.087 | 0.01 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.096 | 0.01 |
| mRNA | CP724714 | GDSC1000 | pan-cancer | AAC | 0.083 | 0.01 |
| mRNA | RDEA119 | FIMM | pan-cancer | AAC | -0.4 | 0.01 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.073 | 0.02 |